in ,

Genentech, HHS Form Drug Development Partnership

Genentech, HHS Form Drug Development Partnership - top government contractors - best government contracting event
https://executivebiz-media.s3.amazonaws.com/2022/08/19/30/9f/c3/a0/b7/6f/d4/64/Executive-Biz.png

Genentech, HHS Form Drug Development Partnership - top government contractors - best government contracting eventThe Department of Health and Human Services has partnered with Genentech to develop medicines that can help address national health security requirements under an “other transaction” agreement.

HHS’ Biomedical Advanced Research and Development Authority and the biotechnology firm agreed to share costs of developing a drug portfolio for potential commercialization in compliance with the Pandemic and All Hazards Preparedness Act of 2006, the department said Monday.

The agency will provide $43M to support a five-year study on the efficacy of baloxavir marboxil to treat patients hospitalized for severe seasonal or pandemic influenza viruses.

BARDA will also allocate $19M to help Genentech further develop alteplase as a treatment for cast formation or acute lung injuries that resulted from inhaling sulfur mustard gas.

The partnership seeks to advance the drug known under the Activase brand and used to treat stroke, heart attack and pulmonary embolism.

The agreement represents BARDA’s eight OTA.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Industry News

Mitre Unveils Medical Device Cybersecurity Framework; John Kreger Quoted - top government contractors - best government contracting event
Mitre Unveils Medical Device Cybersecurity Framework; John Kreger Quoted
SAIC Lands CMS Comms Campaign Support Subcontract; Bob Genter Quoted - top government contractors - best government contracting event
SAIC Lands CMS Comms Campaign Support Subcontract; Bob Genter Quoted